I

Ipsen Global

Global biopharma focused on specialty care

Global Medical Affairs Director Rare Diseases

Biology & BiotechConfirmed live in the last 24 hours
Full-timeNo salary listedHybrid

About the Job

Requirements

  • An MD, PhD, or PharmD (or equivalent scientific/clinical training) is required.
  • A strong scientific foundation and clinical understanding of rare diseases or related therapeutic areas is required.
  • Extensive experience in medical affairs within the biopharmaceutical industry is required.
  • Extensive experience in late-phase development, global medical planning, and lifecycle management is required.

Responsibilities

  • Lead the development and implementation of the Global Medical Plan for assigned rare disease assets, integrating the evidence generation plan, thought leader engagement strategy, and medical communications roadmap.
  • Serve as a core member of the cross-functional asset team, aligning medical priorities with clinical development, regulatory, commercial, and market access strategies.
  • Contribute to indication-specific medical budget planning and ensure efficient allocation of resources in line with strategic objectives.
  • Drive the design and execution of global and international clinical studies and real-world evidence programs tailored to rare disease populations.
  • Support affiliate-led studies by providing strategic and scientific input, reviewing protocols, and guiding execution to ensure consistency with global priorities.
  • Ensure compliance with Good Clinical Practice, ethical standards, and internal medical governance, and establish fit-for-purpose oversight mechanisms for data-generating activities.
  • Develop and sustain collaborative relationships with global and local key opinion leaders, patient advocacy groups, and academic centers of excellence.
  • Represent the company at international congresses, scientific symposia, advisory boards, and high-level stakeholder engagements, contributing to rare disease discourse as a medical voice.
  • Partner with external stakeholders to identify research collaboration, policy-shaping, and medical education opportunities aligned with the Global Medical Affairs strategy.
  • Create, validate, and deliver scientific and educational materials for healthcare professionals, internal stakeholders, and patient communities.
  • Support local and regional training programs, ensuring consistent messaging and scientific understanding across markets.
  • Curate and disseminate relevant scientific publications, insights, and competitive intelligence to internal teams in a timely and actionable manner.
  • Capture and synthesize insights from medical field interactions, advisory boards, and external engagements to inform lifecycle management, clinical trial design, and access strategy.
  • Identify emerging trends and data gaps in the rare disease landscape and proactively adjust medical strategy.
  • Act as the rare disease medical expert within the organization, providing strategic and scientific input across functions and geographies.
  • Independently lead high-impact initiatives addressing scientific, clinical, or strategic challenges within the asset scope.
  • Contribute to the long-term vision for rare disease assets from early development through launch and postapproval stages.

Desired Qualifications

  • Prior clinical or academic research experience in rare diseases or similarly complex therapeutic areas is highly desirable.

About the Company

Ipsen Global

Global biopharma focused on specialty care

Ipsen is a global biopharmaceutical company that concentrates on specialty care, developing and marketing medicines for oncology, neuroscience, and rare diseases. Its products work by treating specific high-need conditions, ranging from historical diarrhea treatment Smecta to modern targeted therapies in cancer and neurological disorders. The company differentiates itself through a focused portfolio in niche therapeutic areas, growth via strategic acquisitions, and a long-standing family heritage that shaped its international expansion and IPO-driven capital for expansion. Its goal is to address unmet medical needs worldwide by providing effective therapies for patients with serious or rare conditions.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boulogne-Billancourt, France
Founded
2005

Recently Posted Jobs

Explore more opportunities at Ipsen Global

See more jobs